• #62 Jon Weidanz: Weeding Out Cancer with Immunotherapies

  • Apr 26 2022
  • Length: 32 mins
  • Podcast
#62 Jon Weidanz: Weeding Out Cancer with Immunotherapies By cover art

#62 Jon Weidanz: Weeding Out Cancer with Immunotherapies

Listen for free

View show details

  • Summary

  • Abexxa Biologics is changing how we treat cancer. Using immunotherapy, Jon Weidanz is treating cancer through novel biotechnology that targets cancer cells and boosts immune systems of patients. Jon and Debra Weidanz are the co-founders of the biotech company Abexxa Biologics, that was acquired by Boehringer Ingelheim (BI) in 2021. Jon shares how he raised capital from BI venture funds, how Abexxa won their “golden ticket” competition and how they went from lab discovery to acquisition in just a few years.
    Show more Show less
Show more Show less
activate_proofit_target_DT_control

What listeners say about #62 Jon Weidanz: Weeding Out Cancer with Immunotherapies

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available